Skip to content
★ Sign in to follow
EQ

Erin Quirk

CEO
Terns Pharmaceuticals, Inc.
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 25 Jan 2024 for Terns Pharmaceuticals, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Erin Quirk: trading record in brief

One trade, one date: on 25 January 2024, Erin Quirk disclosed a share grant in Terns Pharmaceuticals, Inc. No broader history exists yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Erin Quirk

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total

1 of 1 declaration